Biobank Sample Management and Storage System refers to integrated hardware and software solutions that enable the collection, cataloguing, preservation, and retrieval of biological specimens for research and clinical use. The market underpins precision medicine, genomics, and drug discovery, making it a strategic asset for life‑science institutions. The Biobank Sample Management and Storage System market size was estimated at $1.15 billion in 2025, and the market forecast projects growth to $1.78 billion by 2033, reflecting a CAGR of 6.5% (2026‑2033). This growth outlook is driven by expanding biobank initiatives, heightened regulatory mandates for sample traceability, and advances in automation and cryogenic technologies. Key forces shaping industry expansion include the shift toward AI‑enabled LIMS platforms, stricter data‑integrity regulations (e.g., GDPR, HIPAA), and intensified competition among global equipment providers. North America remains the largest market, while Asia‑Pacific emerges as the fastest‑growing region, fueled by government‑backed biobanking programs in China and India.